Dr. Matthew J. Olnes, MD

Dr. Olnes practices at Alaska Native Medical Center in Anchorage, Alaska, part of Alaska Native Tribal Health Consortium.

Dr. Olnes' NPI, 1396760021, was assigned on July 13, 2006. Dr. Olnes holds Alaska license 5841.

Dr. Olnes' primary practice is Alaska Native Medical Center, at 4315 Diplomacy Dr, Anchorage, AK 99508 in Anchorage Borough. The practice phone is (907) 563-2662.

Dr. Olnes' primary practice is Alaska Native Medical Center in Anchorage, Alaska, part of Alaska Native Tribal Health Consortium. Dr. Olnes is also affiliated with Mt. Edgecumbe Medical Center. The medical group on file is Alaska Native Medical Center. Dmand AI also links Dr. Olnes to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Olnes practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Olnes' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Olnes is licensed in Alaska.

CMS data shows 419 Medicare services from Dr. Olnes across 3 procedure codes in 2024, all of them office visits, for 210 Medicare patients. Medicare paid $34,817 for them.

CMS counts 210 Medicare patients who saw Dr. Olnes in 2024. The largest group is 65 to 74, with 102 patients. 73% of them have high blood pressure, and 55% have high cholesterol. 37% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Olnes' median patient age at 71, with 57% women.

In 2024, Dr. Olnes wrote 644 Medicare Part D claims for 99 patients. 75% of them were for generic drugs. CMS names the drug for 334 of them, across 19 drugs with 11 or more claims each, at $461,335 in total drug cost. In 2023, CMS named 318 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Olnes for performance year 2024, reported as part of a group. Dr. Olnes accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Olnes as offering telehealth.

Dmand AI links 27 papers to Dr. Olnes, published from 2010 to 2024. 2013 was the busiest year, with 3. The most frequent topics are Myelodysplastic Syndromes, Alaska Natives and Anemia, Aplastic. Dr. Olnes has published most often in Cancers (Basel). Dr. Olnes' most frequent co-authors are Phillip Scheinberg, MD, Shira Y. Perl, MD and Cynthia Elizabeth Dunbar, MD.

CMS Open Payments shows 50 general payments to Dr. Olnes from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Bristol-Myers Squibb Company paid the most, $307.